News
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune ... 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late ...
Initiated VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune ® HPV in HPV16-Positive Head and Neck Cancer Conference call and webcast today at 8:00 a.m. Eastern Time PRINCETON, N.J., March 27, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback